Works matching IS 25233548 AND DT 2022 AND VI 42 AND IP 7
Results: 10
Cover Image, Volume 42, Issue 7.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. i, doi. 10.1002/cac2.12333
- By:
- Publication type:
- Article
Gene amplification‐driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A‐YTHDF2‐dependent in lung adenocarcinoma.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. 609, doi. 10.1002/cac2.12325
- By:
- Publication type:
- Article
PKCβII–ACSL4 pathway mediating ferroptosis execution and anti‐tumor immunity.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. 583, doi. 10.1002/cac2.12319
- By:
- Publication type:
- Article
Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. 648, doi. 10.1002/cac2.12318
- By:
- Publication type:
- Article
The theory of tumor ecosystem.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. 587, doi. 10.1002/cac2.12316
- By:
- Publication type:
- Article
Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. 627, doi. 10.1002/cac2.12315
- By:
- Publication type:
- Article
Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. 673, doi. 10.1002/cac2.12314
- By:
- Publication type:
- Article
Fascin lysine 471 acetylation cooperates with serine 39 phosphorylation to inhibit actin‐bundling activity and tumor metastasis in esophageal squamous cell carcinoma.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. 668, doi. 10.1002/cac2.12297
- By:
- Publication type:
- Article
ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. 663, doi. 10.1002/cac2.12296
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Communications, 2022, v. 42, n. 7, p. 581, doi. 10.1002/cac2.12171
- Publication type:
- Article